A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Moderna’s Covid-19 vaccine showed 93% efficacy against symptomatic disease through six months, and the company expects to complete its application for full approval from the US Food and Drug ...

Medicines designed to treat COVID-19 won't be available for months, so doctors are looking to drugs already approved for treating other diseases. Coronavirus drugs: Where we are and what we know ...

Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients Families who ate together more often during the pandemic had more positive interactions Masks and smart seating cut ...

COVID-19 drug studies look at repurposed drugs 02:39. Dr. Francis Collins, Director of the National Institutes of Health told 60 Minutes that misinformation about hydroxychloroquine, a drug used ...

There is currently no vaccine or antiviral drug with proven efficacy against SARS-CoV-2, the virus that causes COVID-19, though several clinical trials are underway.

Hope against COVID-19: Drug cuts deaths by a third and ... The ACTION trial is “a nationwide trial in the U.S. that is designed to evaluate the efficacy of a single dose of azithromycin ...

NanoViricides believes that the safety and efficacy of this drug could make it a popular choice, as some of the more popular alternative COVID-19 treatments available are either less safe or are ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment. As with its ...

Doctors in some countries, such as Australia and Japan, are prescribing Merck’s Covid-19 antiviral pill more frequently than Pfizer’s Paxlovid, citing a risk of drug interactions.